Advisor Group’s Insmed INSM Stock Holding History

Advisor Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Buy	224 +7	+3%	+$142	﹤0.01%	4664
2019 Q3	$4K	Hold	217	–	–	﹤0.01%	4753
2019 Q2	$5K	Buy	217 +172	+382%	+$4.79K	﹤0.01%	4680
2019 Q1	$1K	Hold	45	–	–	﹤0.01%	5078
2018 Q4	$1K	Hold	45	–	–	﹤0.01%	4971
2018 Q3	$1K	Hold	45	–	–	﹤0.01%	4974
2018 Q2	$1K	Hold	45	–	–	﹤0.01%	4801
2018 Q1	$1K	Hold	45	–	–	﹤0.01%	4817
2017 Q4	$1K	Sell	45 -350	-89%	-$10.3K	﹤0.01%	4827
2017 Q3	$12K	Sell	395 -250	-39%	-$4.76K	﹤0.01%	3866
2017 Q2	$11K	Buy	645 +600	+1,333%	+$10.2K	﹤0.01%	3865
2017 Q1	$1K	Hold	45	–	–	﹤0.01%	4533
2016 Q4	$1K	Hold	45	–	–	﹤0.01%	4359
2016 Q3	$1K	Buy	+45	New	+$563	﹤0.01%	4305

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Advisor Group's INSM Position: Q4 2019 in Review

Advisor Group increased its Insmed (INSM) stake by 3.2% in Q4 2019, buying an estimated $142 and bringing the position to 224 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4664.

Advisor Group first reported a position in INSM in Q3 2016 and has held it in 14 quarters since. The position peaked at $12K in Q3 2017. 176 funds tracked by Wall St. Rank hold INSM as of Q4 2019.

Advisor Group held 224 shares of Insmed worth $5K as of Q4 2019.
Advisor Group bought 7 Insmed shares in Q4 2019, an estimated $142.
Insmed made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4664 holding.
Advisor Group first reported a position in Insmed in Q3 2016 and has held it in 14 quarters since.
Advisor Group's Insmed position peaked at $12K in Q3 2017.
176 funds tracked by Wall St. Rank held Insmed as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.